Skip to main content
. 2019 Jun 10;6(4):e581. doi: 10.1212/NXI.0000000000000581

Table.

Main clinical characteristic of patients with sIBM participating in the canakinumab study

graphic file with name NEURIMMINFL2019020131t1.jpg